TNF and psoriasis: Methotrexate, which is commonly prescribed in cases of moderate to severe psoriasis, may reduce the risk of cardiovascular events, although most of this evidence is observational and based on patients with rheumatoid arthritis.44 TNF‐alpha inhibitors are increasingly used in the management of patients with moderate to severe psoriasis.